Business disparity between big and small/medium drug companies on the rise.

The top drug companies have made a great business performance for the sales, gross incomes and ordinary incomes despite a general economic recession these days whereas small and medium sized firms were unable to overcome their business difficulties, showing a big contrast between these two groups according to the management analysis by the Yakup Press against the listed drug companies in KOSE a...